Additional clinical trial data needed for US approval of Covaxin: Bharat Biotech

Bharat Biotech didn#39;t clarify the nature of the clinical trial - whether it is a local bridging trial or a Phase -3 trial sought by the USFDA. The vaccine maker said Covaxin has received emergency use authorisation’s from 14 countries with more than 50 countries in the process.

from Moneycontrol Business News https://ift.tt/3g9LGmW